These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33368671)

  • 1. The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner.
    Ikeuchi M; Yuki R; Saito Y; Nakayama Y
    FASEB J; 2021 Jan; 35(1):e21242. PubMed ID: 33368671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Src-induced nuclear localization of YAP is involved in multipolar spindle formation in tetraploid cells.
    Kakae K; Ikeuchi M; Kuga T; Saito Y; Yamaguchi N; Nakayama Y
    Cell Signal; 2017 Jan; 30():19-29. PubMed ID: 27871934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway member Nf2 is required for inner cell mass specification.
    Cockburn K; Biechele S; Garner J; Rossant J
    Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
    Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
    J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.
    Reuven N; Adler J; Meltser V; Shaul Y
    Cell Death Differ; 2013 Oct; 20(10):1330-40. PubMed ID: 23852372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
    Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
    J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus.
    Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L
    Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LATS2 is a tumor suppressor gene of malignant mesothelioma.
    Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
    Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
    Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
    J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
    Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
    Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.
    Paramasivam M; Sarkeshik A; Yates JR; Fernandes MJ; McCollum D
    Mol Biol Cell; 2011 Oct; 22(19):3725-33. PubMed ID: 21832154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.
    Alfthan K; Heiska L; Grönholm M; Renkema GH; Carpén O
    J Biol Chem; 2004 Apr; 279(18):18559-66. PubMed ID: 14981079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
    Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
    Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
    Sekido Y
    Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.
    Boratkó A; Péter M; Csortos C
    Int J Biochem Cell Biol; 2017 Jan; 82():10-17. PubMed ID: 27871951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.